“The Short-Term Efficacy of a Monoclonal Antibody Fragment (brolucizumab) for Treating Neovascular Age-Related Macular Degeneration”. Ukrainian Journal of Ophthalmology , no. 3 (July 2, 2024): 28–32. Accessed August 9, 2026. https://ua.ozhurnal.com/index.php/files/article/view/130.